According to a study published in The BMJ, while e-cigarettes can assist smokers to quit, the number of days of e-cigarette use will determine quit attempt and quit success.
While e-cigarettes can assist smokers to quit, the number of days of e-cigarette use will determine quit attempt and quit success, according to a study published in The BMJ.
Researchers at the University of California, San Francisco, who conducted the study analyzed data from the US Current Population Survey-Tobacco Use Supplement (2001-2002, 2003, 2006-2007, 2010-2011, and 2014-2015), but e-cigarette use was obtained only from the total sample (n = 161,054) from the 2014-2015 survey. Smoking cessation rates were obtained from those who quit smoking cigarettes 12 months prior to the survey (n = 23,270) and compared with the quit rates from the 2010-2011 survey and 3 others.
The primary outcome measures were the rate of attempt to quit cigarette smoking and the rate of successful quitting (meaning having abstained from cigarette smoking for 3 months).
Of the 2014-2015 sample, 22,548 were current smokers and 2136 were recent quitters—38.2% of current smokers and 49.3% of recent quitters had tried e-cigarettes. Of this subpopulation, 11.5% and 19%, respectively, currently use e-cigarettes and were the more likely population to quit smoking: 65.1% vs 40.1%. they also stood a much greater chance of quit success (8.2% vs 4.8%).
The authors write that while only 1.4% of smokers were current users of e-cigarettes in 2010, the number rose to between 15% and 30% by 2014; this meant that comparing the quit rates for those 2 periods would provide the most accurate impact of e-cigarette use on quitting.
E-cigarettes appear to have helped to increase smoking cessation at the population level, the authors conclude based on their study results.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More